Lv5
1080 积分 2023-03-07 加入
US Regulatory Considerations for Modified Release Products
8小时前
求助中
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: some N-nitroso compounds
1个月前
已关闭
Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals
2个月前
已完结
Pathological features of COVID-19-associated liver injury—a preliminary proteomics report based on clinical samples
5个月前
已完结
Trends in innovative drug development in China
1年前
已完结
Hepatic Alveolar Echinococcosis
1年前
已完结
[The mechanism of distant metastases of alveolar hydatid disease]
1年前
已关闭
Pathways for N-Nitroso Compound Formation: Secondary Amines and Beyond
1年前
已完结
RNA Therapeutics
1年前
已完结
RNA Therapeutics（The Evolving Landscape of RNA Therapeutics）
1年前
已关闭
皖公网安备34019202002308
